C181788Level 4
Capecitabine/Margetuximab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of capecitabine and margetuximab that can be used for the treatment of recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive breast cancer.
**Synonyms:** - Capecitabine and Margetuximab - Capecitabine-Margetuximab - Capecitabine-Margetuximab Regimen - Capecitabine/Margetuximab - Capecitabine/Margetuximab-cmkb - Capecitabine/Margetuximab-cmkb Regimen - Margenza/Xeloda - Margetuximab Plus Capecitabine - Margetuximab-Capecitabine - Margetuximab/Capecitabine - Margetuximab/Capecitabine Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C181788Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.